$BITI News
Last published 1y ago
- 1y agoBITIBITOEETHSETHProShares Launches ETFs Targeting 2x Daily Returns of Solana and XRPBusiness WireLaunch of SLON and UXRP expands the largest suite of crypto-linked funds in the U.S. ProShares, the world's leader in leveraged and inverse funds and a pioneer of crypto-linked ETFs, today announced the expansion of
- 2y agoBITIBOILDUGEFU+17ProShares Announces ETF Share SplitsBusiness WireProShares, a premier provider of ETFs, announced today forward and reverse share splits on 22 of its ETFs. The splits will not change the total value of a shareholder's investment. Forward Splits ProShares will
- 2y agoBITIBITOEETHETHD+2ProShares Launches ETFs Targeting 2x and -2x Daily Ether ReturnsBusiness WireETHT targets 2x daily ether returns, while ETHD targets -2x daily ether returns and is the first ETF of its kind in the U.S. ProShares, a premier provider of ETFs, has expanded its product lineup with today's launch
- 2y agoBITIBITOEETHSETHProShares to Launch ETFs Targeting 2x and -2x Daily Ether ReturnsBusiness WireETHT will target 2x daily ether returns, while ETHD will target -2x daily ether returns and will be the first ETF of its kind in the U.S. ProShares, a premier provider of ETFs, announced today the upcoming launch of
- 2y agoBETEBETHBITIBITO+4ProShares Launches First ETF to Target 2x Daily Bitcoin ReturnsBusiness WireAlso launches first ETF to target -2x daily bitcoin returns Today, ProShares, a premier provider of ETFs, is launching ProShares Ultra Bitcoin ETF (BITU), the first ETF to target 2x daily bitcoin returns. At the same
- 3y agoBETEBETHBITIBITO+2ProShares Launches World's First Short Ether-Linked ETFBusiness WireSETH Provides Investors With Opportunity to Profit on Days When Ether Drops ProShares, the global leader in crypto-linked ETFs, announced today the launch of ProShares Short Ether Strategy ETF (SETH), the world's
- 4y agoBITIBITOProShares Bitcoin Short Strategy ETF (BITI) Trades Over 870,000 Shares on Second Trading DayBusiness WireBITI offers investors the opportunity to potentially profit when the daily price of bitcoin declines ProShares, a premier provider of ETFs and the largest provider of bitcoin-linked ETFs* in the United States, announced today that its new short bitco
- 5y agoATHXBITIASTXAthersys Announces CEO TransitionBusiness WireCLEVELAND, Ohio--(BUSINESS WIRE)--Athersys, Inc. (Nasdaq: ATHX), a regenerative medicine company developing MultiStem® cell therapy, today announced that Dr. Gil Van Bokkelen has stepped down as Chairman and Chief Executive Officer, effective immediately. The Athersys Board has appointed William (B.J.) Lehmann, the Company’s President and Chief Operating Officer, as Interim Chief Executive Officer ...
- 10y agoACORBTH1VBITIFinal Results of the Subsequent Offer Period of Acorda Therapeutics' Tender Offer for All of the Shares, American Depositary Shares, Stock Options, Share Units and Warrants in Biotie Therapies Corp.Business WireARDSLEY, N.Y.--(BUSINESS WIRE)--The subsequent offer period under the voluntary public tender offer by Acorda Therapeutics, Inc. (Nasdaq:ACOR) ("Acorda" or the "Offeror") to purchase all of the issued and outstanding shares ("Shares"), American Depositary Shares ("ADSs"), stock options, share units and warrants (such securities, collectively, the "Equity Interests") in Biotie Therapies Corp (Nasda ...
- 10y agoACORBTH1VBITICompletion of Acorda Therapeutics' Voluntary Tender Offer for All of the Issued and Outstanding Shares, American Depositary Shares, Stock Options, Share Units and Warrants in Biotie Therapies Corp. and Matters Related TheretoBusiness WireARDSLEY, N.Y.--(BUSINESS WIRE)--On 11 March 2016, Acorda Therapeutics, Inc. (Nasdaq:ACOR) ("Acorda" or the "Offeror") commenced a voluntary public tender offer to purchase all of the issued and outstanding shares ("Shares"), American Depositary Shares ("ADSs"), stock options ("Option Rights"), share units ("Share Rights") and warrants ("Warrants") (such securities, collectively, the "Equity Intere ...
- 10y agoACORBTH1VBITIFinal Results of Acorda Therapeutics' Voluntary Tender Offer for All of the Issued and Outstanding Shares, American Depositary Shares, Stock Options, Share Units and Warrants in Biotie Therapies Corp. and Commencement of a Subsequent Offer PeriodBusiness WireNEW YORK--(BUSINESS WIRE)--On 11 March 2016, Acorda Therapeutics, Inc. (Nasdaq: ACOR) ("Acorda" or the "Offeror") commenced a voluntary public tender offer to purchase all of the issued and outstanding shares ("Shares"), American Depositary Shares ("ADSs"), stock options ("Option Rights"), share units ("Share Rights") and warrants ("Warrants") (such securities, collectively, the "Equity Interests" ...
- 10y agoACORBTH1VBITIAcorda Therapeutics Announces Preliminary Tender Offer Results and Acceptance of the Shares, American Depositary Shares, Stock Options, Share Units and Warrants in Biotie Therapies Corp. Tendered in Tender OfferBusiness WireNEW YORK--(BUSINESS WIRE)--On 11 March 2016, Acorda Therapeutics, Inc. (Nasdaq: ACOR) ("Acorda" or the "Offeror") commenced a voluntary public tender offer to purchase all of the issued and outstanding shares ("Shares"), American Depositary Shares ("ADSs"), stock options ("Option Rights"), share units ("Share Rights") and warrants ("Warrants") (such securities, collectively, the "Equity Interests" ...
- 10y agoACORBTH1VBITIAcorda Therapeutics Supplements the Tender Offer Document Relating to the Voluntary Public Tender Offer for All of the Issued and Outstanding Shares, American Depositary Shares, Stock Options, Share Units and Warrants in Biotie Therapies Corp. on 22 March 2016Business WireARDSLEY, N.Y.--(BUSINESS WIRE)--As announced on 10 March 2016, Acorda Therapeutics, Inc. (Nasdaq: ACOR) ("Acorda" or the "Offeror") has on 11 March 2016 commenced a voluntary public tender offer (the "Tender Offer") to purchase all of the issued and outstanding shares ("Shares"), American Depositary Shares ("ADSs"), stock options ("Option Rights"), share units ("Share Rights") and warrants ("Warra ...
- 10y agoACORBTH1VBITIAcorda Therapeutics Supplements Tender Offer Document Relating to the Voluntary Public Tender Offer for All of the Issued and Outstanding Shares, American Depositary Shares, Stock Options, Share Units and Warrants in Biotie Therapies on 18 March 2016Business WireARDSLEY, N.Y.--(BUSINESS WIRE)--As announced on 10 March 2016, Acorda Therapeutics, Inc. (Nasdaq: ACOR) ("Acorda" or the "Offeror") has on 11 March 2016 commenced a voluntary public tender offer (the "Tender Offer") to purchase all of the issued and outstanding shares ("Shares"), American Depositary Shares ("ADSs"), stock options ("Option Rights"), share units ("Share Rights") and warrants ("Warra ...
- 10y agoACORBTH1VBITIAcorda Therapeutics, Inc. Will Commence the Voluntary Public Tender Offer for All of the Issued and Outstanding Shares, American Depositary Shares, Stock Options, Share Units and Warrants in Biotie Therapies Corp. on 11 March 2016Business WireARDSLEY, N.Y.--(BUSINESS WIRE)--As announced on 19 January 2016, Acorda Therapeutics, Inc. (Nasdaq: ACOR) ("Acorda" or the "Offeror") and Biotie Therapies Corp. (Nasdaq Helsinki: BTH1V;Nasdaq: BITI) ("Biotie" or the "Company") have on 19 January 2016 entered into a Combination Agreement under which they agree to combine the operations of Acorda and Biotie. In order to effect the combination, Acord ...
- 10y agoACORBTH1VBITIAcorda Has Filed Tender Offer Document Relating to Public Tender Offer For Biotie Therapies with Finnish Financial Supervisory AuthorityBusiness WireARDSLEY, N.Y.--(BUSINESS WIRE)--As announced on January 19, 2016, Acorda Therapeutics, Inc. (Nasdaq:ACOR) (“Acorda”) and Biotie Therapies Corp. (Nasdaq Helsinki: BTH1V; Nasdaq: BITI) (“Biotie”) have entered into a Combination Agreement pursuant to which Acorda will make a voluntary public tender offer in Finland and in the United States to acquire all of the issued and outstanding shares, American ...
- 10y agoACORBTH1VBITIAcorda Announces Expiration of the Hart-Scott-Rodino Waiting Period for Its Tender Offer for Biotie TherapiesBusiness WireARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq:ACOR) today announced that the waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (HSR), for its tender offer for Biotie Therapies Corp. (Nasdaq Helsinki: BTH1V; Nasdaq: BITI) has expired.
- 10y agoACORBITIAcorda to Acquire Biotie TherapiesBusiness WireARDSLEY, N.Y.--(BUSINESS WIRE)--Acorda Therapeutics, Inc. (Nasdaq: ACOR) today announced that it entered into an agreement to acquire Biotie Therapies Corp. (Nasdaq Helsinki BTH1V; NASDAQ: BITI) for €23.5680 per ADS in cash, or the equivalent of $25.60 per ADS based on an exchange rate of 1.0864 U.S. dollars to euros, which values Biotie at approximately $363 million.